Raffles Medical Group Ltd
RAFLF
$0.8073
$0.05737.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.82% | 8.12% | 6.83% | -1.58% | -9.36% |
| Total Other Revenue | -22.97% | -22.97% | -22.97% | -35.90% | -43.23% |
| Total Revenue | 10.77% | 8.07% | 6.78% | -1.65% | -9.44% |
| Cost of Revenue | 8.11% | 6.35% | 5.95% | 8.86% | 11.98% |
| Gross Profit | 14.11% | 10.22% | 7.81% | -12.15% | -27.04% |
| SG&A Expenses | 12.38% | 16.55% | 23.02% | 9.68% | -1.81% |
| Depreciation & Amortization | 18.25% | 15.26% | 13.69% | 14.48% | 15.18% |
| Other Operating Expenses | 7.79% | 18.15% | 33.17% | 33.21% | 33.19% |
| Total Operating Expenses | 9.78% | 10.06% | 11.82% | 10.70% | 9.41% |
| Operating Income | 19.30% | -5.46% | -21.12% | -48.67% | -63.64% |
| Income Before Tax | 5.43% | -14.10% | -26.95% | -43.34% | -54.06% |
| Income Tax Expenses | 5.43% | -5.17% | -12.64% | -32.16% | -45.46% |
| Earnings from Continuing Operations | 5.42% | -17.09% | -31.40% | -46.71% | -56.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 83.60% | 91.57% | 96.29% | 50.93% | -40.65% |
| Net Income | 6.39% | -16.30% | -30.72% | -46.68% | -56.92% |
| EBIT | 19.30% | -5.46% | -21.12% | -48.67% | -63.64% |
| EBITDA | 21.41% | 1.32% | -12.32% | -39.91% | -56.28% |
| EPS Basic | 7.00% | -15.89% | -30.19% | -46.55% | -57.07% |
| Normalized Basic EPS | 20.63% | -3.43% | -18.77% | -46.79% | -62.20% |
| EPS Diluted | 7.92% | -15.72% | -30.92% | -47.07% | -57.22% |
| Normalized Diluted EPS | 21.28% | -3.02% | -18.84% | -46.77% | -62.17% |
| Average Basic Shares Outstanding | -0.16% | -0.13% | -0.10% | 0.03% | 0.16% |
| Average Diluted Shares Outstanding | -1.07% | -0.42% | 0.23% | 0.40% | 0.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.01% | -0.07% | -0.10% | 0.17% | 0.45% |